الصفحة الرئيسية>>Signaling Pathways>> GPCR/G protein>> Glucagon Receptor>>PF-06882961

PF-06882961

رقم الكتالوجGC38832

PF-06882961 هو محفز فعال عن طريق الفم لمستقبل ببتيد شبيه بالجلوكاجون 1 (GLP-1R).

Products are for research use only. Not for human use. We do not sell to patients.

PF-06882961 التركيب الكيميائي

Cas No.: 2230198-02-2

الحجم السعر المخزون الكميّة
1mL*10 mM(in DMSO)
181٫00
متوفر
1mg
57٫00
متوفر
5mg
116٫00
متوفر
10mg
174٫00
متوفر
25mg
349٫00
متوفر
50mg
528٫00
متوفر
100mg
792٫00
متوفر
200mg
1188٫00
متوفر
500mg
1783٫00
متوفر

Tel:(909) 407-4943 Email: sales@glpbio.com

مراجعات العميل

بناء على آراء العملاء.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

PF-06882961 is a potent, orally bioavailable agonist of the glucagon-like peptide-1 receptor (GLP-1R)[1][2].

PF-06882961 (3-240 mg per day) shows mild to moderate damage to the heart, moderate to severe effects on the thymus gland (which helps with managing infection), mild to moderate stomach ulcers at the highest dose level given in the rat[3].PF-06882961 (3-240 mg per day) results one death in an earlier 2-week monkey study at the highest PF-06882961 dose given in that study. No deaths are seen in the 6-week monkey study or any other monkey studies at any of the doses given[3]. Animal Model: 4-week rat[3]

[1]. 20th SCI/RSC Medicinal Chemistry Symposium. [2]. MÉndez M, et al. Design, Synthesis, and Pharmacological Evaluation of Potent Positive Allosteric Modulators of the Glucagon-like Peptide-1 Receptor (GLP-1R). J Med Chem. 2019 Oct 23. [3]. POSSIBLE SIDE EFFECTS AND RISKS OF THE STUDY DRUG AND PROCEDURES.

مراجعات

Review for PF-06882961

Average Rating: 5 ★★★★★ (Based on Reviews and 9 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for PF-06882961

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.